Ren Pharma Sciences Ltd

Ren Pharma Sciences Ltd is an active company incorporated on 8 May 2019 with the registered office located in London, Greater London. Ren Pharma Sciences Ltd was registered 6 years ago.

Watch Company

Status

Active

Active since incorporation

Company No

11983548

Private limited company

Age

6 years

Incorporated 8 May 2019

Size

Micro

Turnover is under £1M

Balance sheet is under £500,000

Under 10 employees

Confirmation

Due Soon

Dated 8 November 2024 (1 year ago)

Next confirmation dated 8 November 2025

Due by 22 November 2025 (10 days remaining)

Last change occurred 2 years 11 months ago

Accounts

Submitted

For period 1 Apr ⟶ 31 Mar 2025 (12 months)

Accounts type is Micro Entity

Next accounts for period 31 March 2026

Due by 31 December 2026 (1 year 1 month remaining)

Learn more about Ren Pharma Sciences Ltd

Contact Update Details

Address

Office Gold, Building 7 Floor 5, Chiswick Park,
566 Chiswick High Road,
London,
W4 5YG
England

Address changed on 10 Jul 2025 (4 months ago)

Previous address was Office Gold, Building 3 Chiswick Park, 566 Chiswick High Road, London W4 5YA England

Companies in W4 5YG

Telephone

Unreported

Email

Unreported

Website

Unreported

See All Contacts

People

Officers

2

Shareholders

2

Controllers (PSC)

2

Mrs Sowmya Renikindi

PSC • Director • British • Lives in England • Born in Apr 1990

Mr Naresh Renikindi

PSC • Director • British • Lives in England • Born in Jun 1982

See Key People

Shareholders, PSCs & Group Structure

See who truly controls a company with full PSC, Shareholder, and Group Structure exploration

See All Shareholders, PSCs & Group Structure

Mutual Companies

Ren Therapeutics Ltd

Sowmya Renikindi is a mutual person.

Active

RBC Pharmaceuticals Limited

Naresh Renikindi is a mutual person.

Active

See All Mutual Companies

Financials

Net Assets, Total Assets & Total Liabilities (2020–2025)

Period Ended

31 Mar 2025

For period 31 Mar ⟶ 31 Mar 2025

Traded for 12 months

Cash in Bank

Unreported

Same as previous period

Turnover

Unreported

Same as previous period

Employees

7

Increased by 1 (+17%)

Total Assets

£91.01K

Decreased by £237.28K (-72%)

Total Liabilities

-£90.76K

Decreased by £15.2K (-14%)

Net Assets

£247

Decreased by £222.08K (-100%)

Debt Ratio (%)

100%

Increased by 67.45% (+209%)

See 10 Year Full Financials

Latest Activity

Micro Accounts Submitted

3 Months Ago on 24 Jul 2025

Registered Address Changed

4 Months Ago on 10 Jul 2025

Registered Address Changed

8 Months Ago on 28 Feb 2025

Confirmation Submitted

1 Year Ago on 11 Nov 2024

Micro Accounts Submitted

1 Year 2 Months Ago on 14 Aug 2024

Confirmation Submitted

2 Years Ago on 8 Nov 2023

Micro Accounts Submitted

2 Years 1 Month Ago on 2 Oct 2023

Micro Accounts Submitted

2 Years 11 Months Ago on 30 Nov 2022

Confirmation Submitted

2 Years 11 Months Ago on 22 Nov 2022

Mrs Sowmya Renikindi (PSC) Details Changed

3 Years Ago on 13 Sep 2022

Get Alerts

Get Credit Report

Discover Ren Pharma Sciences Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you

See All Credit Score & Limits

Documents

Micro company accounts made up to 31 March 2025

Submitted on 24 Jul 2025

Registered office address changed from Office Gold, Building 3 Chiswick Park, 566 Chiswick High Road, London W4 5YA England to Office Gold, Building 7 Floor 5, Chiswick Park, 566 Chiswick High Road, London, W4 5YG on 10 July 2025

Submitted on 10 Jul 2025

Registered office address changed from 15 Heath Park Court Romford RM2 5UA United Kingdom to Office Gold, Building 3 Chiswick Park, 566 Chiswick High Road, London W4 5YA on 28 February 2025

Submitted on 28 Feb 2025

Confirmation statement made on 8 November 2024 with no updates

Submitted on 11 Nov 2024

Micro company accounts made up to 31 March 2024

Submitted on 14 Aug 2024

Confirmation statement made on 8 November 2023 with no updates

Submitted on 8 Nov 2023

Micro company accounts made up to 31 March 2023

Submitted on 2 Oct 2023

Micro company accounts made up to 31 March 2022

Submitted on 30 Nov 2022

Confirmation statement made on 22 November 2022 with updates